Moclobemide is a member of the class of benzamides that is benzamide substituted by a chloro group at position 4 and a 2-(morpholin-4-yl)ethyl group at the nitrogen atom. It functions as a reversible monoamine oxidase inhibitor and is used to treat depression. Among its listed roles, it functions as a xenobiotic, an environmental contaminant and an antidepressant. It belongs to the class of monochlorobenzenes, a member of morpholines and a member of benzamides. It is grouped under the following drug class(es): Neurotransmitter agents, Psychotropic agents and Serotonin agents. Its therapeutic use is listed as antidepressants. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Aurorix, Manerix, Moclamine and NovoMoclobemide. Its PubChem CID is 4235.
Moclobemide
| CAS No | 71320-77-9 |
|---|---|
| Molecular Formula | C13H17ClN2O2 |
| Molecular Weight | 268.74 g/mol |
| Synonyms | 4-chloro-N-(2-morpholin-4-ylethyl)benzamide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Moclobemide is a member of the class of benzamides that is benzamide substituted by a chloro group at position 4 and a 2-(morpholin-4-yl)ethyl group at the nitrogen atom.
The listed CAS number is 71320-77-9.
The listed molecular formula is C13H17ClN2O2.
The listed molecular weight is 268.74 g/mol.
4-chloro-N-(2-morpholin-4-ylethyl)benzamide.
The source lists Aurorix, Manerix, Moclamine and NovoMoclobemide.